--- title: "Barrow Hanley Q1 2026: Deep Value, No Megacap Tech" type: research slug: barrow-hanley-q1-2026-deep-value-no-megacap-tech canonical_url: https://13finsight.com/research/barrow-hanley-q1-2026-deep-value-no-megacap-tech published_at: 2026-05-23T22:17:22.864Z updated_at: 2026-05-23T22:17:26.061Z author: Marcus Chen author_title: Senior Market Analyst author_url: https://13finsight.com/authors/marcus-chen word_count: 526 locale: en source: 13F Insight --- # Barrow Hanley Q1 2026: Deep Value, No Megacap Tech > Barrow Hanley's $30.5B book holds no megacap tech — pharma, energy, and utilities lead. In Q1 2026 it added GE HealthCare +83% and HP Enterprise +57%. Barrow Hanley Mewhinney & Strauss, a long-running deep-value manager, reported a $30.52B U.S. equity book for the quarter ended March 31, 2026 (Form 13F-HR, accession 0000313028-26-000021, filed 2026-05-13), up 1.6% on the quarter. What stands out is the same thing that defines the firm: there is no megacap technology at the top. Instead, Barrow Hanley's largest positions span pharmaceuticals, energy, utilities, and consumer names — the classic hunting ground of a value investor. The book is led by Merck (MRK) at 3.12%, Chevron (CVX) at 2.87%, and GE HealthCare (GEHC) at 2.77% — and GE HealthCare was the quarter's standout move, with Barrow Hanley raising its share count by 83%. The firm also added 57% to Hewlett Packard Enterprise (HPE) and 12% to oil producer Permian Resources (PR). For readers used to megacap-dominated 13Fs, Barrow Hanley is a reminder that a large institutional book can be built entirely on value sectors. A diversified value book Barrow Hanley runs a broadly diversified portfolio of about 377 positions, with the ten largest accounting for only about 25% of the book. After Merck, Chevron, and GE HealthCare come cruise operator Carnival (CCL), utility Entergy (ETR), Permian Resources, and another utility, Pinnacle West (PNW). The sector mix is the tell: energy (Chevron, Exxon (XOM), Permian Resources), utilities (Entergy, Pinnacle West), healthcare (Merck, GE HealthCare), and value-priced technology (Microchip (MCHP), HPE). These are dividend-paying, cash-generative businesses bought on valuation — the opposite of a growth-momentum book. The quarter's adds Barrow Hanley's most active moves were additions to specific value names. The 83% increase in GE HealthCare and 57% in Hewlett Packard Enterprise were the largest, with a 12% add to Permian Resources extending its energy exposure. The main trim was Entergy, down 12%. Adding to a medical-imaging company and an enterprise-hardware name while keeping a heavy energy and utility base reflects a value manager finding specific opportunities rather than making a top-down sector call. The diversified, dividend-oriented structure stayed intact. What it means for 13F readers Barrow Hanley is a clean example of deep-value investing in 13F form — diversified, dividend-tilted, and entirely outside the megacap-tech cluster that dominates most large filings. The GE HealthCare and HPE adds are the quarter's clearest signals of where the firm sees value. Track the firm's quarter-over-quarter holdings on the Barrow Hanley filer page. FAQ What is Barrow Hanley? Barrow Hanley Mewhinney & Strauss is a long-established deep-value asset manager. It reported a $30.52B U.S. equity 13F book for the quarter ended March 31, 2026, across about 377 positions. What are Barrow Hanley's largest holdings? Its five largest positions are Merck (3.12%), Chevron (2.87%), GE HealthCare (2.77%), Carnival (2.51%), and Entergy (2.46%) — a value book spanning healthcare, energy, and utilities. What did Barrow Hanley buy in Q1 2026? Barrow Hanley raised GE HealthCare by 83% and Hewlett Packard Enterprise by 57% in share terms, and added 12% to Permian Resources, while trimming Entergy by 12%. Does Barrow Hanley own megacap technology stocks? Not at the top of its book. Barrow Hanley's largest positions are value sectors — pharmaceuticals, energy, utilities, and consumer names — rather than the megacap-tech leaders that dominate most large 13Fs. ## FAQ ### What is Barrow Hanley? Barrow Hanley Mewhinney & Strauss is a long-established deep-value asset manager. It reported a $30.52B U.S. equity 13F book for the quarter ended March 31, 2026, across about 377 positions. ### What are Barrow Hanley's largest holdings? Its five largest positions are Merck (3.12%), Chevron (2.87%), GE HealthCare (2.77%), Carnival (2.51%), and Entergy (2.46%) — a value book spanning healthcare, energy, and utilities. ### What did Barrow Hanley buy in Q1 2026? Barrow Hanley raised GE HealthCare by 83% and Hewlett Packard Enterprise by 57% in share terms, and added 12% to Permian Resources, while trimming Entergy by 12%. ### Does Barrow Hanley own megacap technology stocks? Not at the top of its book. Barrow Hanley's largest positions are value sectors — pharmaceuticals, energy, utilities, and consumer names — rather than the megacap-tech leaders that dominate most large 13Fs. --- Source: 13F Insight — https://13finsight.com/research/barrow-hanley-q1-2026-deep-value-no-megacap-tech Author: Marcus Chen — https://13finsight.com/authors/marcus-chen Last updated: 2026-05-23T22:17:26.061Z